Selank + Semax Research Guide: Combined Anxiolytic + Nootropic Vial
This combination vial pairs Selank (anxiolytic) with Semax (nootropic) — two Russian-developed neuropeptides frequently paired in cognitive research.
Component mechanisms
Selank — tuftsin-derived heptapeptide studied for anxiolytic effects via GABAergic modulation and expression changes in serotonergic and monoaminergic systems.
Semax — ACTH(4-7) analog studied for BDNF and NGF upregulation in cortical and hippocampal tissue.
Sourcing & purity
Research-grade material should be ≥99% pure by HPLC with peptide content confirmed via mass spectrometry. Redline Bio material ships with batch documentation; independent third-party COAs are published on the lab reports page as testing returns.
Compliance reminder
Sold and distributed for laboratory research use only. Not approved by the FDA for human consumption, diagnosis, treatment, or cure of any disease. Researchers are responsible for compliance with all applicable institutional, state, and federal regulations.
Frequently asked questions
Why combine them?
The two peptides act on distinct but complementary pathways — Selank on GABAergic and tuftsin-related immunomodulatory pathways, Semax on BDNF/NGF upregulation — and are commonly paired in Russian nootropic research literature.